ATXN2 (ataxin-2)
Assets acting on this target.
- Class
- ATXN2-lowering agent (modality not stated in source)
- Notes
- verified in session 2026-08-25 (owner-delegated review, correction of a wrong draft); source: https://clinicaltrials.gov/study/NCT04494256
Related mechanisms
ATXN2 (ataxin-2) drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| BIIB105 | Biogen, Ionis Pharmaceuticals | antisense oligonucleotide | Phase 1/2 | Not recorded |
| SRP-1004 | Sarepta Therapeutics | RNAi (siRNA) | Phase 1 | Phase 1 in Spinocerebellar Ataxia Type 2 |